Allowing Bedside Nurses to Order C. Difficile Testing Cuts Time to Results
The researchers found that the difference in time to obtain the result before and after the policy change was statistically significant.
Diagnosis & Disease Information
Conducting Cancer Clinical Trials During the COVID-19 Crisis: Ethical Challenges, Considerations
Patients with cancer enrolled in clinical trials during the COVID-19 pandemic represent a particularly vulnerable patient population.
Antibiotic Prophylaxis Shown to Reduce Infection Risk for Patients With Newly Diagnosed Multiple Myeloma
Prophylactic antibiotics trended toward reducing infection risk at 3 months if given in first 2 to 3 months after MM diagnosis; however, it had no effect on mortality rates.
Preventing, Managing Cytomegalovirus Infection in the Setting of Hematopoietic Stem Cell Transplantation
ECIL 7 releases its guidelines for managing CMV infection in patients with hematologic malignancies and after HSCT.
Managing Infectious Risk in Patients With Hematologic Malignancies
In this review, researchers discussed strategies for identifying and treating infection in patients undergoing intensive chemotherapy.
Metronidazole, Vancomycin Recommended for C Difficile in Pediatric Oncology, HSCT
An international multidisciplinary panel of experts in pediatric oncology and infectious diseases convened to develop recommendations for the prevention and treatment of C difficile infection in pediatric patients with cancer or who are undergoing HSCT.
Ciprofloxacin Plus Doxycycline Reduces Infection Rate in Multiple Myeloma Post-ASCT
A health outcomes analysis of 419 patients with multiple myeloma sought to determine if cipro-doxy was more effective than cipro alone in reducing the incidence of neutropenic fever and infections, both significant causes of morbidity and death for these patients.
Evidence-Based Approach Improves Rate of Colon Surgical Site Infections
Study results presented at the NACNS 2018 Annual Conference demonstrate the efficacy of SSI bundle element compliance and multidisciplinary clinical collaboration in reducing colon surgical site infections.
Use of Antiseptic Swabs Significantly Reduce Incidence of CLABSIs
Results of a cross-over trial presented at the NACNS 2018 Annual Conference demonstrate the efficacy of antiseptic device swabs in reducing central line-associated bloodstream infections in oncology patients with central venous catheters.
Peer-Driven Education Leads to Improved Sepsis Bundle Compliance, Outcomes
Results of a project involving periodic surveys of nursing staff intended to assess familiarity with sepsis screening tool and sepsis bundle was presented at the NACNS 2018 Annual Conference.sep
- Loading...
Loading...
Next post in Oncology Nursing
Loading... 
Loading...